Refractory Tophaceous Gout — RACP Adult Medicine MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: A — Switch to febuxostat
Persistent hyperuricaemia and flares despite maximum allopurinol warrants switching to febuxostat (an alternative xanthine oxidase inhibitor). Febuxostat 80–120 mg daily may achieve urate targets when allopurinol fails. It is not renally cleared, making it useful in CKD (though cardiovascular safety requires monitoring per CARES trial). Target urate is <0.36 mmol/L (<0.30 for tophaceous gout).
Reference: ARA – 2024 – Gout Guidelines; EULAR 2024 Gout; eTG Rheumatology 2024